GLSI peer analysis
Greenwich LifeSciences (GLSI) against its competitors: price, today's move, 1-year return and market value side by side.
GLSI and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AGEN Agenus | $6.22 | -1.03% | 43.43% | $281.66M |
| ATOS Atossa Therapeutics | $1.87 | -3.11% | -84.42% | $18.66M |
| CGTX Cognition Therapeutics | $0.64 | -6.03% | -58.79% | $60.75M |
| HURA TuHURA Biosciences | $1.33 | -4.32% | -35.12% | $87.46M |
| IMMX Immix Biopharma | $7.30 | -2.41% | 73.40% | $611.83M |
| IRD Opus Genetics | $4.05 | 0.37% | 115.69% | $391.93M |
| ONCY Oncolytics Biotech | $0.34 | -8.14% | -67.32% | $46.27M |
| SEER Seer | $1.48 | -5.73% | -26.00% | $82.61M |
| SRZN Surrozen | $30.04 | -7.05% | 131.43% | $224.62M |
| TVGN Tevogen | $6.22 | 3.67% | -72.00% | $25.90M |
| GLSI Greenwich LifeSciences | $18.77 | 36.41% | 125.60% | $275.51M |
- GLSI's peers: AGEN (Agenus), ATOS (Atossa Therapeutics), CGTX (Cognition Therapeutics), HURA (TuHURA Biosciences), IMMX (Immix Biopharma), IRD (Opus Genetics), ONCY (Oncolytics Biotech), SEER (Seer).
Updated 2026-11-17 23:41 UTC